Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 18, 2026

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold
09:37

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold

Published on: October 23, 2015

[The bioresorbable coronary scaffold].

Mariëlla E C J Hassell1, Tim P van de Hoef, Peter Damman

  • 1Academisch Medisch Centrum, afd. Cardiologie, Amsterdam, the Netherlands.

Nederlands Tijdschrift Voor Geneeskunde
|September 7, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of coronary endothelial dysfunction using contemporary coronary function testing.

International journal of cardiology·2024
Same author

Aortic versus distal pressure for derivation of hyperaemic microvascular resistance: From the ILIAS registry.

International journal of cardiology·2024
Same author

Age-related structural remodelling of the coronary circulation.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2024
Same author

2024 ESC Guidelines for the management of chronic coronary syndromes.

European heart journal·2024
Same author

Do electrocardiographic changes induced during intracoronary vasospasm provocation testing reflect those during spontaneous angina episodes in patients with vasospastic angina?: a case series.

European heart journal. Case reports·2024
Same author

Impact of hyperaemic stenosis resistance on long-term outcomes of stable angina in the ILIAS Registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2024
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

New bioresorbable vascular scaffolds (BVS) offer a promising alternative to permanent metal stents for percutaneous coronary interventions. These scaffolds may eliminate the risk of stent thrombosis and improve future treatment options.

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science

Context:

  • Permanent metal stents improve percutaneous coronary interventions but drug-eluting stents can impede endothelialization, increasing thrombosis risk.
  • The antiproliferative drugs in drug-eluting stents prevent natural vessel healing, leading to potential long-term complications.
  • The temporary need for vessel support suggests permanent metallic stents may be unnecessary long-term.

Purpose:

  • To introduce bioresorbable vascular scaffolds (BVS) as a novel alternative to permanent metallic stents.
  • To highlight the potential of BVS to mitigate risks associated with current stent technologies.
  • To explore the advantages of BVS in the context of future coronary interventions.

Summary:

  • Bioresorbable vascular scaffolds (BVS), made from polylactic acid, are designed to be completely resorbed within 18-24 months.

More Related Videos

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
08:16

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies

Published on: November 5, 2016

Related Experiment Videos

Last Updated: May 18, 2026

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold
09:37

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold

Published on: October 23, 2015

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
08:16

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies

Published on: November 5, 2016

  • This resorption is expected to eliminate the risk of late stent thrombosis and reduce complications from permanent metal implants.
  • BVS offer a theoretical advantage for patients requiring future interventions, as metal stents can be a limiting factor.

    • Impact:

    • BVS may reduce the incidence of stent thrombosis and related adverse events.
    • The temporary nature of BVS could enhance long-term vascular health and remodeling.
    • This technology could significantly improve management strategies for patients with coronary artery disease, particularly those with complex anatomy or high risk for reintervention.